Literature DB >> 19430274

10 questions about 4-aminopyridine and the treatment of multiple sclerosis.

Christopher T Bever1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430274     DOI: 10.1097/NRL.0b013e3181679be5

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


× No keyword cloud information.
  2 in total

Review 1.  Dalfampridine extended release: in multiple sclerosis.

Authors:  Claudine M Chwieduk; Gillian M Keating
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

2.  Treatment of walking impairment in multiple sclerosis with dalfampridine.

Authors:  Andrew R Blight
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.